Format

Send to

Choose Destination
Bioorg Med Chem. 2018 Jun 1;26(10):2700-2707. doi: 10.1016/j.bmc.2017.06.052. Epub 2017 Jul 1.

Therapeutic peptides: Historical perspectives, current development trends, and future directions.

Author information

1
Ferring Research Institute, Inc., 4245 Sorrento Valley Blvd, San Diego, CA 92121, USA.
2
Ferring Research Institute, Inc., 4245 Sorrento Valley Blvd, San Diego, CA 92121, USA. Electronic address: Michael.Dunn@ferring.com.

Abstract

Peptide therapeutics have played a notable role in medical practice since the advent of insulin therapy in the 1920s. Over 60 peptide drugs are approved in the United States and other major markets, and peptides continue to enter clinical development at a steady pace. Peptide drug discovery has diversified beyond its traditional focus on endogenous human peptides to include a broader range of structures identified from other natural sources or through medicinal chemistry efforts. We maintain a comprehensive dataset on peptides that have entered human clinical studies that includes over 150 peptides in active development today. Here we provide an overview of the peptide therapeutic landscape, including historical perspectives, molecular characteristics, regulatory benchmarks, and a therapeutic area breakdown.

KEYWORDS:

Clinical development; Drug discovery; Drugs; G protein-coupled receptors; Peptides

PMID:
28720325
DOI:
10.1016/j.bmc.2017.06.052
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center